Marine peptides in breast cancer: Therapeutic and mechanistic understanding - 18/09/21
pages | 12 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Breast cancer is the most prevalent invasive form of cancer in females and posing a great challenge for overcoming disease burden. The growth in global cancer deaths mandates the discovery of new efficacious natural anti-tumor treatments. In this regard, aquatic species offer a rich supply of possible drugs. Studies have shown that several marine peptides damage cancer cells by a broad range of pathways, including apoptosis, microtubule balance disturbances, and suppression of angiogenesis. Traditional chemotherapeutic agents are characterized by a plethora of side effects, including immune response suppression. The discovery of novel putative anti-cancer peptides with lesser toxicity is therefore necessary and timely, especially those able to thwart multi drug resistance (MDR). This review addresses marine anti-cancer peptides for the treatment of breast cancer.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Breast cancer is the most prevalent invasive form of cancer in females. |
• | The troubling rise in global cancer deaths mandates search for new natural anti-tumor medicines. |
• | Marine peptides damage cancer cells by apoptosis, microtubule balance disturbances, and suppression of angiogenesis. |
• | Marine anti-cancer peptides appear less toxic to normal cells than traditional treatments. |
• | Marine peptides are capable of blocking MDR affording an efficient treatment modality. |
Abbreviations : Akt, APAF-1, BAD, BAK, BAX, Bcl-2, Bcl-xL, Casp, CXCR4, Cyt c, ErbB3, ERK1/2, FoxO3a, HIF1α, MMP, Mcl-1, MDR, MRP1, PARP, P-gp, PI3K, ROS, STAT3, TNBC, VEGF
Keywords : Marine peptides, Protein hydrolysate, Apoptosis, Metastasis, Cell cycle arrest
Plan
Vol 142
Article 112038- octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?